Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer.
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.
Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection.